Metabonomic Biomarkers of Plaque Burden and Instability in Patients With Coronary Atherosclerotic Disease After Moderate Lipid‐Lowering Therapy

Our findings highlight the potential of nuclear magnetic resonance-based metabolomics in identifying novel biomarkers of plaque burden and instability. Metabolites related to plaque burden may facilitate noninvasive assessment of CAD prognosis.

Authors

Institutions

Publication Details

Journal
Journal of the American Heart Association
Published
2024-12-10
DOI
https://doi.org/10.1161/jaha.124.036906
Citations
12
Primary Topic
Metabolomics and Mass Spectrometry Studies
Type
article
Field-Weighted Citation Impact
2.81

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metabonomic Biomarkers of Plaque Burden and Instability in Patients With Coronary Atherosclerotic Disease After Moderate Lipid‐Lowering Therapy

Chenhao Lin, Lingfeng Luo, Mengyao Yu, Shalaimaiti Shali et al.
12 citations
Journal of the American Heart Association
Metabolomics and Mass Spectrometry Studies
2.81
article

Metabonomic Biomarkers of Plaque Burden and Instability in Patients With Coronary Atherosclerotic Disease After Moderate Lipid‐Lowering Therapy

Chenhao Lin, Lingfeng Luo, Mengyao Yu, Shalaimaiti Shali, Guo‐Chong Chen, Juying Qian, Runda Wu, Zhendong Mei, Huiru Tang, Yan Zheng, Qingxia Huang, Zhonghan Sun, Zhen Wang, Junbo Ge, Lili Xu, Liang Sun, Hongyi Wu, Yijing Lu, Kang Yao, Yuxiang Dai
article en
12 citations

Abstract

Our findings highlight the potential of nuclear magnetic resonance-based metabolomics in identifying novel biomarkers of plaque burden and instability. Metabolites related to plaque burden may facilitate noninvasive assessment of CAD prognosis.

Journal of the American Heart AssociationVol. 13(24)
Fudan University (CN), Soochow University (CN), Zhongshan Hospital (CN), YangPu Geriatric Hospital (CN), State Key Laboratory of Genetic Engineering
National Natural Science Foundation of China, China Postdoctoral Science Foundation, Shanghai Hospital Development Center, Shanghai Clinical Research Center, Program of Shanghai Academic Research Leader
Good health and well-being
Openalex Percentile: Top 9%
Metabolomics and Mass Spectrometry Studies
2.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.